Galmed Pharmaceuticals Ltd. (GLMD) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Galmed Pharmaceuticals Ltd. (GLMD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.8M, listed on NASDAQ, employing roughly 6 people, carrying a beta of 0.74 to the broader market. Galmed Pharmaceuticals Ltd. Led by Allen Baharaff, public since 2014-03-12.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for GLMD as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →